We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held Equity + Options
1
year
Top 10 Avg Time Held Equity + Options
2.3
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
826
Figma
FIG
$11.4B
| $15.4M | 0.01% |
852,900
-971,425
| -53% | -$19.5M |
2025 Q3
3 quarters
|
|
827
Regenxbio
RGNX
$456M
| $15.4M | 0.01% |
+1,284,950
| New | +$10.7M |
2026 Q2
0 quarters
|
|
828
Sprouts Farmers Market
SFM
$6.07B
| $15.3M | 0.01% |
181,476
-316,841
| -64% | -$25.6M |
2023 Q2
12 quarters
|
|
829
State Street SPDR S&P Retail ETF
XRT
$399M
| $15.3M | 0.01% |
174,406
+166,406
| +2,080% | +$14M |
2023 Q2
12 quarters
|
|
830
PJT Partners
PJT
$3.5B
| $15.3M | 0.01% |
+101,163
| New | +$15.6M |
2026 Q2
0 quarters
|
|
831
Cinemark Holdings
CNK
$4.46B
| $15.3M | 0.01% |
480,909
-758,614
| -61% | -$22.5M |
2021 Q1
21 quarters
|
|
832
iShares A.I. Innovation and Tech Active ETF
BAI
$12.6B
| $15.2M | 0.01% |
+288,998
| New | +$13.1M |
2026 Q2
0 quarters
|
|
833
Lithium Americas
LAC
$788M
| $15.2M | 0.01% |
3,955,764
+3,441,917
| +670% | +$16.4M |
2026 Q1
1 quarter
|
|
834
Graco
GGG
$13.3B
| $15.1M | 0.01% |
199,989
-207,656
| -51% | -$16.4M |
2024 Q1
9 quarters
|
|
835
Trinity Capital Inc
TRIN
$1.52B
| $15.1M | 0.01% |
+844,773
| New | +$13.9M |
2026 Q2
0 quarters
|
|
836
CALL
UnitedHealth
UNH
$361B
| $15.1M | 0.01% |
36,300
+19,800
| +120% | +$7.34M |
2025 Q2
4 quarters
|
|
837
CCC Intelligent Solutions
CCC
$4.49B
| $15M | 0.01% |
2,913,079
+1,628,895
| +127% | +$8.06M |
2025 Q1
5 quarters
|
|
838
Colgate-Palmolive
CL
$74.8B
| $15M | 0.01% |
163,762
+159,762
| +3,994% | +$14M |
2025 Q4
2 quarters
|
|
839
Bel Fuse Inc Class A
BELFA
$2.43B
| $14.9M | 0.01% |
51,332
+41,674
| +431% | +$10.1M |
2025 Q3
3 quarters
|
|
840
Weave Communications
WEAV
$595M
| $14.9M | 0.01% |
2,493,881
+1,615,650
| +184% | +$8.8M |
2026 Q1
1 quarter
|
|
841
AbCellera Biologics
ABCL
$3.83B
| $14.9M | 0.01% |
1,902,191
+1,542,508
| +429% | +$7.54M |
2026 Q1
1 quarter
|
|
842
Goldman Sachs
GS
$256B
| $14.9M | 0.01% |
14,749
-195,251
| -93% | -$190M |
2025 Q2
4 quarters
|
|
843
Globus Medical
GMED
$10.3B
| $14.9M | 0.01% |
188,541
-374,089
| -66% | -$31.8M |
2023 Q1
13 quarters
|
|
844
Pool Corp
POOL
$6.24B
| $14.9M | 0.01% |
69,318
-211,392
| -75% | -$42.2M |
2026 Q1
1 quarter
|
|
845
Dave Inc
DAVE
$4.62B
| $14.9M | 0.01% |
39,946
-5,912
| -13% | -$1.54M |
2024 Q2
8 quarters
|
|
846
Hasbro
HAS
$13.9B
| $14.9M | 0.01% |
180,164
-1,068,790
| -86% | -$96.2M |
2023 Q1
13 quarters
|
|
847
Texas Pacific Land
TPL
$24B
| $14.8M | 0.01% |
33,886
+4,097
| +14% | +$1.66M |
2025 Q1
5 quarters
|
|
848
Becton Dickinson
BDX
$52.1B
| $14.8M | 0.01% |
97,825
-1,489,972
| -94% | -$223M |
2022 Q4
14 quarters
|
|
849
Hut 8
HUT
$8.31B
| $14.8M | 0.01% |
128,083
+106,840
| +503% | +$10.4M |
2025 Q4
2 quarters
|
|
850
Halozyme
HALO
$13.8B
| $14.7M | 0.01% |
188,354
+67,348
| +56% | +$4.59M |
2024 Q4
6 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.